Breast cancer issues?
Hello Doctor: My mother has stage III breast cancer that has metastasized to the lymph nodes.
She underwent surgery for breast and lymph node removal but has not received chemotherapy.
Currently, her blood tests show normal CEA levels, but one item, the cytokeratin fragment 21-1, has a specification of below 3.3.
Her initial value was 3.82, and after a month of re-testing, the value increased to over 5.
Could you please answer the following questions: (1) Why did the value increase to over 5 after one month? What could be the reason? (2) The area around her surgical wound is red, resembling a burn.
Could this be due to lack of lymphatic drainage? (3) Sometimes there is a lump at the wound site, and sometimes there isn't.
What could be the reason for this?
Lin Xiansheng, 30~39 year old female. Ask Date: 2018/01/30
Dr. Chen Yunfang reply Oncology
Hello: Regarding these questions, I am unable to provide answers because 1.
The person who ordered the blood tests for those specific markers is responsible for interpreting their significance.
Moreover, whether a tumor has recurred cannot be determined solely by elevated tumor markers; imaging evidence and pathological examination are also necessary.
2.
I cannot provide an answer without having seen the appearance in person.
3.
Similarly, you should consult the surgeon regarding postoperative wound questions, as they would provide the correct information.
Thank you.
Reply Date: 2018/01/30
More Info
Understanding rising tumor markers in Stage III breast cancer can be a complex issue, especially when considering the emotional and physical toll that a cancer diagnosis and treatment can take on both patients and their families. Your mother’s situation, involving Stage III breast cancer with lymph node involvement, raises several important questions regarding her health and the implications of rising tumor markers.
1. Why did the tumor marker (CK19) increase from 3.82 to over 5 in one month?
The increase in the tumor marker, specifically the cytokeratin fragment 21-1 (CK19), can be attributed to several factors. Tumor markers are substances that can be found in the blood and may indicate the presence of cancer. However, they are not exclusively specific to cancer and can be influenced by various conditions.
In your mother’s case, the rise in CK19 levels could be due to several reasons:
- Tumor Activity: The most concerning reason could be that the cancer is becoming more active or aggressive. This could indicate that the cancer is progressing or that there are residual cancer cells that are producing more of this marker.
- Inflammation or Infection: If there is inflammation or an infection around the surgical site, this could also lead to elevated levels of tumor markers. The body’s response to inflammation can sometimes mimic or elevate tumor marker levels.
- Surgical Recovery: After surgery, the body goes through a healing process that can temporarily affect various blood markers, including tumor markers.
It is crucial to discuss these results with your mother's oncologist, who can provide a more tailored interpretation based on her overall clinical picture.
2. Is the redness around the surgical site due to lack of lymphatic drainage?
The redness around the surgical site could indeed be related to lymphatic drainage issues, especially since your mother underwent lymph node removal. When lymph nodes are removed, the normal flow of lymphatic fluid can be disrupted, leading to a condition known as lymphedema. This can cause swelling, redness, and discomfort in the affected area.
However, redness can also indicate an infection or inflammation. It is essential to monitor this closely. If the redness persists, worsens, or is accompanied by other symptoms such as fever, increased pain, or discharge, it is crucial to seek medical attention promptly.
3. Why does the surgical site sometimes have a lump?
The presence of a lump at the surgical site can be attributed to several factors:
- Scar Tissue Formation: After surgery, the body forms scar tissue as part of the healing process. This can sometimes feel like a lump under the skin.
- Fluid Accumulation: Seromas (fluid collections) can occur after surgery, especially in areas where lymph nodes have been removed. These can present as lumps and may resolve on their own or require drainage.
- Infection or Abscess: If there is an infection, it can lead to localized swelling and the formation of an abscess, which may feel like a lump.
- Residual Tumor: In some cases, if there are residual cancer cells, they may present as a lump. This is why regular follow-up and imaging studies are essential.
In conclusion, it is vital for your mother to maintain regular follow-ups with her healthcare team. They can provide the necessary evaluations and interventions based on her symptoms and the results of her tumor marker tests. Understanding the implications of rising tumor markers and changes in her surgical site will help in managing her condition effectively. Encourage her to communicate openly with her medical team about any concerns, as they can provide the best guidance tailored to her specific situation.
Similar Q&A
Understanding Rising Cancer Markers in Stage III Breast Cancer
Hello, my mother has stage III breast cancer and is scheduled for surgery. She has already undergone four rounds of chemotherapy, but during her recent check-up, we found that her cancer markers are higher than before she started chemotherapy. However, the doctors have said she i...
Dr. Chen Sirong reply Oncology
Dear Da-Ming, I apologize for the delay in my response as I am on leave this week. I hope you can come to my clinic on October 24 to discuss your concerns. Regarding the elevated cancer markers, it is important to note that not every increase indicates the presence of cancer, an...[Read More] Understanding Rising Cancer Markers in Stage III Breast Cancer
Understanding Cancer Markers: Insights on Stage 3B Rectal Cancer
Dear Doctor: For a patient with stage 3B sigmoid colon cancer, after surgery, the cancer marker level decreased from over 50 to around 4. Is this a significant reduction? I understand that cancer markers are not always accurate, but a decrease is still a positive outcome, right?
Dr. Lai Yicheng reply Oncology
Hello Huang Xiaomei: The current clinical application of tumor markers is primarily for monitoring treatment. The interpretation of elevated markers helps determine whether patients' levels return to normal after surgery, radiation, or chemotherapy, and whether they rise aga...[Read More] Understanding Cancer Markers: Insights on Stage 3B Rectal Cancer
Understanding Triple-Negative Breast Cancer: Risks, Treatments, and Prognosis
Hello Doctor, I would like to ask you a question regarding my mother, who is currently 61 years old. She was recently diagnosed with breast cancer (Luminal B type, grade 2) and has just undergone a partial mastectomy and sentinel lymph node biopsy (4 nodes), with no lymph node me...
Dr. Chen Sirong reply Oncology
Hello, 1. I would like to ask the doctor if the risk of recurrence for my mother is high. Using this algorithm, IHC4 = 32 > 30 indicates high risk, with ER = 90, PR = 90, Her2 = 1, and Ki67 = 30 for calculating the IHC4 score. 2. Since the doctor recommends both chemotherap...[Read More] Understanding Triple-Negative Breast Cancer: Risks, Treatments, and Prognosis
Understanding Stage III Breast Cancer: Progression to Stage IV Timeline
My mother is currently in stage III breast cancer, and it has been almost a month since her last examination. I would like to ask how quickly stage III breast cancer can progress to stage IV.
Dr. Lai Yicheng reply Oncology
Hello: The extent of breast cancer invasion determines the treatment method, which is staged based on tumor size, axillary lymph node involvement, and metastasis to other organs: Stage 0: The breast tumor is no larger than 2 centimeters and there is no lymph node involvement. ...[Read More] Understanding Stage III Breast Cancer: Progression to Stage IV Timeline
Related FAQ
(Oncology)
Terminal Stage(Oncology)
Lymph Node Cancer(Oncology)
Uterus(Oncology)
Pancreatic Cancer(Oncology)
Breast Cancer(Breast and Thyroid)
Blood(Oncology)
Bile Duct Cancer(Oncology)
Rectal Cancer(Oncology)
Axillary Lump(Oncology)